- Home
- NCRA vs PMN Comparison
NCRA vs PMN Comparison
Compare NCRA & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- PMN
- Stock Information
- Founded
- NCRA 2002
- PMN 2004
- Country
- NCRA Taiwan
- PMN Canada
- Employees
- NCRA N/A
- PMN N/A
- Industry
- NCRA Farming/Seeds/Milling
- PMN Pharmaceuticals and Biotechnology
- Sector
- NCRA Consumer Staples
- PMN Health Care
- Exchange
- NCRA Nasdaq
- PMN Nasdaq
- Market Cap
- NCRA 21.4M
- PMN 22.3M
- IPO Year
- NCRA N/A
- PMN N/A
- Fundamental
- Price
- NCRA $1.68
- PMN $0.48
- Analyst Decision
- NCRA
- PMN Strong Buy
- Analyst Count
- NCRA 0
- PMN 3
- Target Price
- NCRA N/A
- PMN $4.33
- AVG Volume (30 Days)
- NCRA 21.4K
- PMN 872.4K
- Earning Date
- NCRA 11-13-2025
- PMN 11-13-2025
- Dividend Yield
- NCRA N/A
- PMN N/A
- EPS Growth
- NCRA N/A
- PMN N/A
- EPS
- NCRA N/A
- PMN N/A
- Revenue
- NCRA $13,865,984.00
- PMN N/A
- Revenue This Year
- NCRA N/A
- PMN N/A
- Revenue Next Year
- NCRA N/A
- PMN N/A
- P/E Ratio
- NCRA N/A
- PMN N/A
- Revenue Growth
- NCRA N/A
- PMN N/A
- 52 Week Low
- NCRA $0.70
- PMN $0.38
- 52 Week High
- NCRA $2.09
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- NCRA 58.30
- PMN 48.54
- Support Level
- NCRA $1.54
- PMN $0.39
- Resistance Level
- NCRA $1.75
- PMN $0.61
- Average True Range (ATR)
- NCRA 0.11
- PMN 0.04
- MACD
- NCRA 0.02
- PMN 0.01
- Stochastic Oscillator
- NCRA 87.27
- PMN 41.14
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.